Literature DB >> 8554715

Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry.

M H Kodsi1, N R Swerdlow.   

Abstract

It has been shown that the acoustic startle reflex is inhibited by weak auditory prepulses presented 30-500 ms prior to the startling stimulus and that this prepulse inhibition (PPI) is modulated by ventral striato-pallidal circuitry. However, dorsal striatal modulation of PPI has not been examined. Cell-specific lesions and intracerebral drug infusions were used to elucidate striatal modulation of PPI. Quinolinic acid lesions of the ventral and caudodorsal striatum significantly decreased PPI, whereas lesions of the rostrodorsal and middorsal striatum did not significantly alter PPI. Infusion of the GABA-A antagonist picrotoxin into the ventral and caudal dorsal pallidum also significantly reduced PPI, whereas rostral pallidal picrotoxin infusion had no significant effect. Thus, PPI in the rat seems to be modulated by both ventral and caudodorsal striato-pallidal circuitry, but not by rostrodorsal or middorsal striato-pallidal projections.

Entities:  

Mesh:

Year:  1995        PMID: 8554715     DOI: 10.1037//0735-7044.109.5.912

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  27 in total

1.  Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

Authors:  R J Carter; L A Lione; T Humby; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice.

Authors:  Philipp Singer; Detlev Boison; Hanns Möhler; Joram Feldon; Benjamin K Yee
Journal:  Eur Neuropsychopharmacol       Date:  2010-07-19       Impact factor: 4.600

Review 3.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

Review 4.  Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.

Authors:  Neal R Swerdlow
Journal:  Neurosci Biobehav Rev       Date:  2012-09-24       Impact factor: 8.989

5.  Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies.

Authors:  Ying Qu; Neal R Swerdlow; Martin Weber; David Stouffer; Loren H Parsons
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

6.  Lesions of the dorsomedial striatum disrupt prepulse inhibition.

Authors:  L C Baldan Ramsey; M Xu; N Wood; C Pittenger
Journal:  Neuroscience       Date:  2011-02-15       Impact factor: 3.590

7.  Therapeutic strategies to avoid long-term adverse outcomes of neonatal antiepileptic drug exposure.

Authors:  Patrick A Forcelli; Megan J Janssen; Lauren A Stamps; Cameron Sweeney; Stefano Vicini; Karen Gale
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

Review 8.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

9.  Differential effects of acute alcohol on prepulse inhibition and event-related potentials in adolescent and adult Wistar rats.

Authors:  Jerry P Pian; Jose R Criado; Cindy L Ehlers
Journal:  Alcohol Clin Exp Res       Date:  2008-09-25       Impact factor: 3.455

10.  Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats.

Authors:  Ying Qu; Richard L Saint Marie; Michelle R Breier; David Ko; David Stouffer; Loren H Parsons; Neal R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2009-09-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.